Pre-Header Contact

800-449-3353 | custserv@rockwellmed.com |

Footer Socials

Pre-Header Menu

Careers | Contact Us

Investor Relations

Financial Statement

Financial Statement

  Year Ending Dec 2020 (Update) Year Ending Dec 2019 (Update) Year Ending Dec 2018 (Update) Year Ending Dec 2017 (Update)
Net Sales 62.20 61.30 63.39 57.30
Revenue 62.20 61.30 63.39 57.30
Total Revenue 62.20 61.30 63.39 57.30
Cost of Revenue 59.47 58.46 64.97 53.60
Cost of Revenue, Total 59.47 58.46 64.97 53.60
Gross Profit 2.73 2.84 -1.58 3.70
Selling/General/Administrative Expense 24.05 30.05 23.08 23.30
Selling/General/Administrative Expenses, Total 24.05 30.05 23.08 23.30
Research & Development 7.09 6.89 6.74 6.32
Litigation 0.00 0.43 1.03 --
Unusual Expense (Income) 0.00 0.43 1.03 --
Total Operating Expense 90.62 95.83 95.83 83.22
Operating Income -28.42 -34.53 -32.44 -25.92
Interest Expense - Non-Operating -1.88 -- -- 0.00
Interest Expense, Net Non-Operating -1.88 -- -- 0.00
Interest Income, Non-Operating 0.24 0.37 0.54 --
Investment Income, Non-Operating 0.01 0.03 -0.22 0.00
Interest/Investment Income, Non-Operating 0.25 0.40 0.31 0.00
Interest Income (Expense), Net-Non-Operating, Total -1.63 0.40 0.31 0.00
Other Non-Operating Income (Expense) -0.84 -- 0.00 --
Other, Net -0.84 -- 0.00 --
Net Income Before Taxes -30.89 -34.13 -32.13 -25.92
Income Tax – Total -- -- -- 0.00
Income After Tax -30.89 -34.13 -32.13 -25.92
Net Income Before Extraordinary Items -30.89 -34.13 -32.13 -25.92
Net Income -30.89 -34.13 -32.13 -25.92
Income Available to Common Excluding Extraordinary Items -30.89 -34.13 -32.13 -25.92
Income Available to Common Stocks Including Extraordinary Items -30.89 -34.13 -32.13 -25.92
Basic Weighted Average Shares 75.62 60.92 52.82 51.07
Basic EPS Excluding Extraordinary Items -0.41 -0.56 -0.61 -0.51
Basic EPS Including Extraordinary Items -0.41 -0.56 -0.61 -0.51
Dilution Adjustment -- -- -- 0.00
Diluted Net Income -30.89 -34.13 -32.13 -25.92
Diluted Weighted Average Shares 75.62 60.92 52.82 51.07
Diluted EPS Excluding Extraordinary Items -0.41 -0.56 -0.61 -0.51
Diluted EPS Including Extraordinary Items -0.41 -0.56 -0.61 -0.51
DPS - Common Stock Primary Issue -- -- -- --
Gross Dividends - Common Stock 0.00 0.00 0.00 0.00
Total Special Items 0.00 0.43 1.03 --
Normalized Income Before Taxes -30.89 -33.70 -31.10 -25.92
Effect of Special Items on Income Taxes 0.00 0.00 0.00 --
Income Taxes Excluding Impact of Special Items 0.00 0.00 0.00 0.00
Normalized Income After Taxes -30.89 -33.70 -31.10 -25.92
Normalized Income Available to Common -30.89 -33.70 -31.10 -25.92
Basic Normalized EPS -0.41 -0.55 -0.59 -0.51
Diluted Normalized EPS -0.41 -0.55 -0.59 -0.51
Amortization of Intangibles, Supplemental -- 0.00 0.00 0.00
Depreciation, Supplemental 0.85 0.79 0.65 0.51
Interest Expense, Supplemental 1.88 -- -- 0.00
Rental Expense, Supplemental 1.61 2.41 2.37 2.46
Stock-Based Compensation, Supplemental 0.48 4.95 4.39 6.95
Research & Development Expense, Supplemental 7.09 6.89 6.74 6.32
Audit-Related Fees, Supplemental -- 0.91 0.99 0.00
Audit-Related Fees -- 0.00 0.00 0.00
Tax Fees, Supplemental -- 0.00 0.00 0.00
All Other Fees Paid to Auditor, Supplemental -- 0.00 0.00 0.00
Gross Margin 4.38 4.63 -2.50 6.46
Operating Margin -45.69 -56.32 -51.18 -45.24
Pretax Margin -49.66 -55.67 -50.68 -45.24
Net Profit Margin -49.66 -55.67 -50.68 -45.24
Normalized EBIT -28.42 -34.10 -31.41 -25.92
Normalized EBITDA -27.57 -33.31 -30.76 -25.41

In millions of USD (except for per share items)

Copyright Refinitiv

Shareholder Tools

Snapshot
Email Alerts
RSS News Feeds